SCHEMBL8909578

SCHEMBL8909578

CC1=C(C(=O)Nc2ccccc2)N=c2cc3c(c(C)c21)=Nc1ccccc1-3

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HPGD P15428 4/20 0.41
RAB9A P51151 5/20 0.37
NPC1 O15118 4/20 0.37
SMN1; SMN2 Q16637 4/20 0.37
ALDH1A1 P00352 1/20 0.37
MAPT P10636 1/20 0.36
KCNK3 O14649 1/20 0.36
KCNK9 Q9NPC2 1/20 0.36
PRKDC P78527 1/20 0.35
ATR Q13535 1/20 0.35
KMT2A Q03164 3/20 0.35
MEN1 O00255 2/20 0.35
TDP1 Q9NUW8 1/20 0.35
TYK2 P29597 1/20 0.35
L3MBTL1 Q9Y468 2/20 0.35
CYP1A2 P05177 1/20 0.35
CYP2C19 P33261 1/20 0.35
CYP3A4 P08684 1/20 0.35
CYP2C9 P11712 1/20 0.35
ALOX12 P18054 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8910714 0.84 ALDH1A1 (0.34) HPGDNPC1SMN1; SMN2ALDH1A1MAPT
SCHEMBL9057850 0.81 MYC (0.36) NR1H4
SCHEMBL8149797 0.78 NPC1 (0.38) HPGDRAB9ANPC1SMN1; SMN2ALDH1A1
SCHEMBL8148024 0.74 TDP2 (0.40) NPC1MAPTKMT2AMEN1CYP1A2
SCHEMBL8153428 0.74 TP53 (0.36) RAB9ANPC1SMN1; SMN2ALDH1A1MAPT
SCHEMBL8146061 0.73 TP53 (0.37) HPGDRAB9ANPC1SMN1; SMN2ALDH1A1
SCHEMBL8141664 0.72 MEN1 (0.33) SMN1; SMN2MAPTKMT2AMEN1
SCHEMBL8150571 0.72 HTT (0.32) SMN1; SMN2ALDH1A1MAPT
SCHEMBL8153452 0.72 LMNA (0.32) SMN1; SMN2MAPT
SCHEMBL8910407 0.72 BCHE (0.39) KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5679694-A LOW TOXICITY AGAINST NORMAL CELL LINES THE WELLCOME FOUNDATION LTD. (GB) 1997-10-21 US disclosed
WO-1994002483-A1 TETRACYCLIC COMPOUNDS PROCESS AND INTERMEDIATES FOR THEIR PREPARATION AND THEIR USE AS ANTITUMOUR AGENTS THE WELLCOME FOUNDATION LIMITED (GB) 1994-02-03 WO disclosed